[1]Locationinpatent:experimentalpartShi,Liqiao;Hu,Rui;Wei,Yanhong;Liang,Ying;Yang,Ziwen;Ke,Shaoyong[EuropeanJournalofMedicinalChemistry,2012,vol.54,p.549-556]
157069-52-8
202146-16-5
20776-61-8
20776-67-4
20776-62-9
2486-71-7
69543-15-3 | 1-(Bromomethyl)cyclopentene | AA00FLH9 | MFCD17015938
69218-46-8 | Ethyl 1H-benzotriazole-1-acetate | AA00FOLG | MFCD00747701
660-78-6 | methyl(3,3,3-trifluoropropyl)silanediol | AA00FTEQ
72296-90-3 | 1-Methoxy-3-phenylpropan-2-aMine | AA00FVF6 | MFCD06248074
67469-75-4 | Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)-,dihydrochloride | AA00FYPC | MFCD00209830
84508-45-2 | Ethyl acetate-1,2-13c2 | AA00G21A | MFCD00037529
82417-45-6 | 2,3-Dichlorobenzenesulfonyl chloride | AA00G2DU | MFCD00051844
76935-75-6 | 3-(2-Amino-ethyl)-aniline | AA00G2MY | MFCD05663958
7681-67-6 | PROPIONYLPROMAZINE HYDROCHLORIDE | AA00G2TC | MFCD01941563
844856-42-4 | 3-Bromo-3'-chlorobiphenyl | AA00G31D | MFCD06201361